Targeted therapies in breast cancer: are heart and vessels also being targeted?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeted therapies in breast cancer: are heart and vessels also being targeted?

Published:2012-06 Issue:3 Volume:14 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Criscitiello Carmen,Metzger-Filho Otto,Saini Kamal S,de Castro Jr Gilberto,Diaz Marie,La Gerche André,de Azambuja Evandro,Piccart-Gebhart Martine J

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/bcr3142.pdf

Reference111 articles.

1. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL: Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science. 1987, 235: 177-182. 10.1126/science.3798106.

2. de Azambuja E, Bedard PL, Suter T, Piccart-Gebhart M: Cardiac toxicity with anti-HER-2 therapies: what have we learned so far?. Target Oncol. 2009, 4: 77-88. 10.1007/s11523-009-0112-2.

3. Lee KF, Simon H, Chen H, Bates B, Hung MC, Hauser C: Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature. 1995, 378: 394-398. 10.1038/378394a0.

4. De Keulenaer GW, Doggen K, Lemmens K: The vulnerability of the heart as a pluricellular paracrine organ: lessons from unexpected triggers of heart failure in targeted ErbB2 anticancer therapy. Circ Res. 2010, 106: 35-46. 10.1161/CIRCRESAHA.109.205906.

5. Zhao YY, Sawyer DR, Baliga RR, Opel DJ, Han X, Marchionni MA, Kelly RA: Neuregulins promote survival and growth of cardiac myocytes. Persistence of ErbB2 and ErbB4 expression in neonatal and adult ventricular myocytes. J Biol Chem. 1998, 273: 10261-10269. 10.1074/jbc.273.17.10261.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bio-markers of immuno-oncology;Journal of Pharmaceutical and Biological Sciences;2024-02-15

2. Time for a New Paradigm in Oncology? Viewpoint of the Radiobiologist;Open Journal of Biophysics;2024

3. Early Echocardiography and ECG Changes Following Radiotherapy in Patients with Stage II-III HER2-Positive Breast Cancer Treated with Anthracycline-Based Chemotherapy with or without Trastuzumab-Based Therapy;Medical Science Monitor;2023-09-11

4. Immuno-oncology trends: preclinical models, biomarkers, and clinical development;Journal for ImmunoTherapy of Cancer;2022-01

5. The Utility of Cardiac Reserve for the Early Detection of Cancer Treatment-Related Cardiac Dysfunction: A Comprehensive Overview;Frontiers in Cardiovascular Medicine;2020-03-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3